Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Buprenorphine | 1 | 2023 | 33 | 0.890 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 161 | 0.750 |
Why?
|
| Video Games | 1 | 2011 | 11 | 0.410 |
Why?
|
| Child Welfare | 1 | 2011 | 39 | 0.400 |
Why?
|
| Health Promotion | 1 | 2011 | 160 | 0.360 |
Why?
|
| Violence | 1 | 2011 | 143 | 0.350 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 130 | 0.340 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2023 | 5 | 0.230 |
Why?
|
| Opiate Substitution Treatment | 1 | 2023 | 30 | 0.230 |
Why?
|
| Pain | 1 | 2023 | 391 | 0.190 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 413 | 0.170 |
Why?
|
| California | 1 | 2011 | 138 | 0.100 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 146 | 0.100 |
Why?
|
| Child Behavior | 1 | 2011 | 48 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 8489 | 0.100 |
Why?
|
| Child Development | 1 | 2011 | 163 | 0.090 |
Why?
|
| Health Policy | 1 | 2011 | 180 | 0.090 |
Why?
|
| Aggression | 1 | 2011 | 320 | 0.080 |
Why?
|
| Adnexa Uteri | 1 | 2006 | 12 | 0.070 |
Why?
|
| Adnexal Diseases | 1 | 2006 | 17 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 636 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2002 | 28 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 153 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 19 | 0.050 |
Why?
|
| Mitogens | 1 | 2000 | 64 | 0.050 |
Why?
|
| Humans | 3 | 2023 | 86643 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 107 | 0.050 |
Why?
|
| Child | 1 | 2011 | 6927 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2002 | 485 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 231 | 0.040 |
Why?
|
| United States | 1 | 2011 | 6672 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 3362 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2006 | 107 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 602 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 15 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2002 | 93 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1991 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 543 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 504 | 0.010 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2000 | 12 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2000 | 21 | 0.010 |
Why?
|
| Thymidine | 1 | 2000 | 59 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 141 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1106 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 636 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 696 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1456 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2330 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 2468 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6509 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 8981 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 3241 | 0.010 |
Why?
|
| Aged | 1 | 2006 | 18415 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 25028 | 0.000 |
Why?
|
| Female | 1 | 2006 | 44532 | 0.000 |
Why?
|
| Animals | 1 | 2000 | 26582 | 0.000 |
Why?
|
| Male | 1 | 2000 | 40965 | 0.000 |
Why?
|